单细胞分析揭示溃疡性结肠炎与克罗恩病结肠和血液的独特免疫细胞特征
该研究采用质谱流式(CyTOF)对87例结肠黏膜和85例外周血单个核细胞进行单细胞分析,比较活动期/非活动期UC、CD患者与对照的免疫细胞群。研究发现IBD患者黏膜中HLA-DR+CD38+ T细胞、CXCR3+浆母细胞及IL1B+巨噬/单核细胞增多,UC与CD各有特异性细胞群扩增。随机森林模型可区分活动期UC与CD。
要点
- IBD患者结肠黏膜HLA-DR+CD38+ T细胞、CXCR3+浆母细胞及IL1B+巨噬/单核细胞增多
- UC黏膜以IL17A+CD161+效应记忆T细胞和IL17A+Treg扩增为特征
- 活动期CD黏膜以IL1B+HLA-DR+CD38+ T细胞及IL1B+树突状细胞等为特征
核心结论
- 单细胞技术识别出活动期或非活动期CD和UC患者黏膜与血液中特异性免疫细胞群,可用于开发靶向不同IBD类型特定细胞群体的疗法。
研究设计与样本
- 研究对87例结肠黏膜样本和85例外周血单个核细胞进行质谱流式(CyTOF)分析,样本来自活动期或非活动期UC或CD患者及对照。
- 研究还进行单细胞RNA测序、流式细胞术和RNA原位杂交验证关键发现,并使用随机森林建模识别组间特征差异。
主要发现
- 与对照相比,IBD患者结肠黏膜中HLA-DR+CD38+ T细胞(包括产生炎性细胞因子的Treg)、CXCR3+浆母细胞及IL1B+巨噬细胞和单核细胞丰度增加。
- UC结肠黏膜以IL17A+CD161+效应记忆T细胞和IL17A+ Treg扩增、HLA-DR+CD56+粒细胞扩增及3型先天淋巴样细胞减少为特征。
- 活动期CD黏膜以IL1B+HLA-DR+CD38+ T细胞、IL1B+TNF+IFNG+初始B细胞、IL1B+树突状细胞(DC)及IL1B+浆细胞样DC为特征。
- 活动期CD外周血单个核细胞与活动期UC不同,表现为IL1B+ Treg、IL1B+ DC、IL1B+浆细胞样DC、IL1B+单核细胞增多及1型先天淋巴样细胞减少。
- 随机森林建模可区分活动期UC与活动期CD的结肠黏膜和血液样本,顶级判别特征包括上述许多细胞群体。
临床怎么用
- 这些免疫细胞特征可能有助于区分UC与CD,并为开发针对不同IBD类型特定细胞群体的靶向治疗提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Studies are needed to determine the mechanisms of mucosal dysregulation in patients with inflammatory bowel diseases (IBDs) and differences in inflammatory responses of patients with ulcerative colitis (UC) vs Crohn's disease (CD). We used mass cytometry (CyTOF) to characterize and compare immune cell populations in the mucosa and blood from patients with IBD and without IBD (controls) at single-cell resolution. METHODS: We performed CyTOF analysis of colonic mucosa samples (n = 87) and peripheral blood mononuclear cells (n = 85) from patients with active or inactive UC or CD and controls. We also performed single-cell RNA sequencing, flow cytometry, and RNA in situ hybridization analyses to validate key findings. We used random forest modeling to identify differences in signatures across subject groups. RESULTS: Compared with controls, colonic mucosa samples from patients with IBD had increased abundances of HLA-DR+CD38+ T cells, including T-regulatory cells that produce inflammatory cytokines; CXCR3+ plasmablasts; and IL1B+ macrophages and monocytes. Colonic mucosa samples from patients with UC were characterized by expansion of IL17A+ CD161+ effector memory T cells and IL17A+ T-regulatory cells; expansion of HLA-DR+CD56+ granulocytes; and reductions in type 3 innate lymphoid cells. Mucosal samples from patients with active CD were characterized by IL1B+HLA-DR+CD38+ T cells, IL1B+TNF+IFNG+ naïve B cells, IL1B+ dendritic cells (DCs), and IL1B+ plasmacytoid DCs. Peripheral blood mononuclear cells from patients with active CD differed from those of active UC in that the peripheral blood mononuclear cells from patients with CD had increased IL1B+ T-regulatory cells, IL1B+ DCs and IL1B+ plasmacytoid DCs, IL1B+ monocytes, and fewer group 1 innate lymphoid cells. Random forest modeling differentiated active UC from active CD in colonic mucosa and blood samples; top discriminating features included many of the cellular populations identified above. CONCLUSIONS: We used single-cell technologies to identify immune cell populations specific to mucosa and blood samples from patients with active or inactive CD and UC and controls. This information might be used to develop therapies that target specific cell populations in patients with different types of IBD.
引用
- Mitsialis V, Wall S, Liu P, et al. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease. Gastroenterology. 2020. PMID: 32428507. doi:10.1053/j.gastro.2020.04.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。